Applicant, as named in the Orange Book

Ipsen

Next listed expiry: Onivyde on 15 Oct 2036. 4 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Onivyde irinotecan hydrochloride	irinotecan hydrochloride	207793	15 Oct 2036	patent
Sohonos · 4 strengths palovarotene	palovarotene	215559	16 Aug 2037	patent, carve-out possible
Bylvay · 4 strengths odevixibat	odevixibat	215498	12 Nov 2041	patent, carve-out possible
Iqirvo elafibranor	elafibranor	218860	5 Mar 2044	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.